Roche's diagnostic division forms strategic alliance; Australian regulators taken to task over PIP implant scandal;

 

 @FierceMedDev: Only a few weeks left to submit your nominations for the 15 fiercest private device developers. Survey | Follow @FierceMedDev

> Australian regulators have been taken to task for not yet determining a local failure rate of recalled PIP breast implants, which used substandard materials. Story

> The Wall Street Journal takes a look at the future of renal denervation devices, led by Medtronic ($MDT) and St. Jude Medical ($STJ), which, if approved in the U.S., could make for a $2.5 billion market, analysts say. Report

> InspireMD's president and co-founder, Asher Holzer, is stepping down from his seat, the Israeli devicemaker announced. He will remain a director at the company and will serve as a consultant for 6 months. Release

> Roche's ($RHHBY) diagnostics division has sealed a strategic alliance deal with med fusion in Texas indented to boost advancement of new molecular diagnostics methods and tech. Release

> Sanuwave Health says it has generated promising preclinical research that shows its Extracorporeal Shock Wave technology device helped stimulate growth of adult stem cells that eventually formed bone. Release

 

Biotech News

 @FierceBiotech: Check out this special report by @MarkHFierce: Stem cell research advances in fits and starts. Report | Follow @FierceBiotech

 @JohnCFierce: Pazdur talks up the new wave of cancer drug apps (20) headed to the FDA this year. Expects rising number of approvals. More | Follow @JohnCFierce

 @RyanMFierce: My report on 5 next-gen software tools for biopharma R&D. Report | Follow @RyanMFierce

> Ceptaris Therapeutics raises $10M after FDA denial. News

> FDA foresees jump in apps for cancer drugs. Story

> BioInvent,ThromboGenics bloodthinner fails to beat Xarelto. More

> Targacept CEO exits after pipeline failures. Article

Pharma News

 @FiercePharma: Abbott unveils exec team to back up pharma spinoff CEO Richard Gonzalez--Dow JonesMore | Follow @FiercePharma

> Appeals court reinstates KV investors' $1.5B lawsuit. More

> ASCO lobbies for fines to combat drug shortages. Story

> Reports: Pfizer to cut 180 jobs at two Irish plants. More

> Some drug recalls slip through FDA-reporting cracks. Article

Biotech Research News

> Cellular changes explain greater breast cancer risk in older women. Story

> Novel technique helps detail Parkinson's modus operandi. Article

> U.K. scientists detect cancer from stray DNA fragments in blood. More

> Synthetic peptide helps defeat recurrent cancer's resistance to treatment. News

Pharma Manufacturing News

> Lipitor losses lead to Pfizer headcount reduction in Ireland. More

> FDA fails to send alerts on 20% of Class I drug recalls. Article

> Court says KV Pharma shareholders have every right to sue. Story

And Finally... Stephen Quake, the co-founder of Helicos BioSciences and three other companies, and a pioneer in genomic sequencing, is this year's $500,000 Lemulson-MIT Prize winner. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.